Menu
Back to Journals » Drug, Healthcare and Patient Safety
Drug, Healthcare and Patient Safety
- View all (168)
- Volume 10, 2018 (12)
- Volume 9, 2017 (11)
- Volume 8, 2016 (13)
- Volume 7, 2015 (20)
- Volume 6, 2014 (22)
- Volume 5, 2013 (23)
- Volume 4, 2012 (18)
- Volume 3, 2011 (15)
- Volume 2, 2010 (25)
- Volume 1, 2009 (9)
Journal Articles:
- 168 records -
Ceftriaxone-associated nephrolithiasis and gallstone in adults
Azarkar G, Mahi Birjand M, Ehsanbakhsh A, Bijari B, Abedini MR, Ziaee M
Drug, Healthcare and Patient Safety 2018, 10:103-108
Published Date: 12 December 2018
Clinical factors predicting drug-induced liver injury due to flucloxacillin
Lindh M, Hallberg P, Yue QY, Wadelius M
Drug, Healthcare and Patient Safety 2018, 10:95-101
Published Date: 21 November 2018
A pilot study on secondhand tobacco exposure: parental knowledge about health impact and feasibility of cessation
Walia H, Miller R, Tumin D, Tobias JD, Sebastian R
Drug, Healthcare and Patient Safety 2018, 10:89-94
Published Date: 12 October 2018
Predictors of non adherence to antiretroviral therapy at an urban HIV care and treatment center in Tanzania
Sangeda RZ, Mosha F, Aboud S, Kamuhabwa A, Chalamilla G, Vercauteren J, Van Wijngaerden E, Lyamuya EF, Vandamme AM
Drug, Healthcare and Patient Safety 2018, 10:79-88
Published Date: 21 August 2018
Development and validation of a questionnaire to self-assess patient knowledge of direct oral anticoagulants (KODOA-test)
Metaxas C, Albert V, Stahl M, Hersberger KE, Arnet I
Drug, Healthcare and Patient Safety 2018, 10:69-77
Published Date: 20 July 2018
Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum]
Muto S, Okada T, Yasuda M, Tsubouchi H, Nakajima K, Horie S
Drug, Healthcare and Patient Safety 2018, 10:67-68
Published Date: 16 July 2018
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
Mouhamed Y, Vishnyakov A, Qorri B, Sambi M, Frank SMS, Nowierski C, Lamba A, Bhatti U, Szewczuk MR
Drug, Healthcare and Patient Safety 2018, 10:45-66
Published Date: 11 June 2018
Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits
Molina KC, Fairman KA, Sclar DA
Drug, Healthcare and Patient Safety 2018, 10:37-43
Published Date: 3 May 2018
Evaluating cardiac risk: exposure response analysis in early clinical drug development
Grenier J, Paglialunga S, Morimoto BH, Lester RM
Drug, Healthcare and Patient Safety 2018, 10:27-36
Published Date: 18 April 2018
Evaluation of vancomycin therapy in the adult ICUs of a teaching hospital in southern Iran
Vazin A, Mahi Birjand M, Darake M
Drug, Healthcare and Patient Safety 2018, 10:21-26
Published Date: 5 April 2018
Calculating reading ease score of patient package inserts in Iran
Zarea Gavgani V, Mirzadeh-Qasabeh S, Hanaee J, Hamishehkar H
Drug, Healthcare and Patient Safety 2018, 10:9-19
Published Date: 19 March 2018
Prevalence of medication errors in primary health care at Bahrain Defence Force Hospital – prescription-based study
Aljasmi F, Almalood F, Al Ansari A
Drug, Healthcare and Patient Safety 2018, 10:1-7
Published Date: 7 February 2018
Older adults and high-risk medication administration in the emergency department
Kim M, Mitchell SH, Gatewood M, Bennett KA, Sutton PR, Crawford CA, Bentov I, Damodarasamy M, Kaplan SJ, Reed MJ
Drug, Healthcare and Patient Safety 2017, 9:105-112
Published Date: 8 November 2017
Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial
Muto S, Okada T, Yasuda M, Tsubouchi H, Nakajima K, Horie S
Drug, Healthcare and Patient Safety 2017, 9:93-104
Published Date: 25 October 2017
A suspected case of autoinduction of voriconazole metabolism in a patient with cerebral aspergillosis
Ferguson MJ, Randles ML, de Freitas DG
Drug, Healthcare and Patient Safety 2017, 9:89-91
Published Date: 8 September 2017
Early rehospitalizations of frail elderly patients – the role of medications: a clinical, prospective, observational trial
Ekerstad N, Bylin K, Karlson BW
Drug, Healthcare and Patient Safety 2017, 9:77-88
Published Date: 18 August 2017
Potential drug–drug interactions in inpatients treated at the Internal Medicine ward of Tikur Anbessa Specialized Hospital
Tesfaye ZT, Nedi T
Drug, Healthcare and Patient Safety 2017, 9:71-76
Published Date: 14 August 2017
Prediction of drug-related problems in diabetic outpatients in a number of hospitals, using a modeling approach
Al-Taani GM, Al-Azzam SI, Alzoubi KH, Darwish Elhajji FW, Scott MG, Alfahel H, Aldeyab MA
Drug, Healthcare and Patient Safety 2017, 9:65-70
Published Date: 28 July 2017
Adaptation of the European Commission-recommended user testing method to patient medication information leaflets in Japan
Yamamoto M, Doi H, Yamamoto K, Watanabe K, Sato T, Suka M, Nakayama T, Sugimori H
Drug, Healthcare and Patient Safety 2017, 9:39-63
Published Date: 14 June 2017
Update on the renal toxicity of iodinated contrast drugs used in clinical medicine
Andreucci M, Faga T, Serra R, De Sarro G, Michael A
Drug, Healthcare and Patient Safety 2017, 9:25-37
Published Date: 22 May 2017
Patient safety attitudes of pharmacy students in an Ethiopian university: a cross-sectional study
Tegegn HG, Abebe TB, Ayalew MB, Bhagavathula AS
Drug, Healthcare and Patient Safety 2017, 9:19-24
Published Date: 8 May 2017
Update on the usage and safety of epinephrine auto-injectors, 2017
Posner LS, Camargo CA Jr
Drug, Healthcare and Patient Safety 2017, 9:9-18
Published Date: 21 March 2017
Quantifying the relationship between patient characteristics and involvement in developing and implementing a treatment plan
Roy NT, Ulrich EE
Drug, Healthcare and Patient Safety 2017, 9:1-8
Published Date: 16 January 2017
Development and validation of evaluation tools of nursing students’ clinical pharmacology unit
Navabi N, Ghaffari F, Shamsalinia A, Faghani S
Drug, Healthcare and Patient Safety 2016, 8:101-109
Published Date: 15 December 2016
Implementation of co-trimoxazole preventive therapy policy for malaria in HIV-infected pregnant women in the public health facilities in Tanzania
Kamuhabwa AAR, Gordian R, Mutagonda RF
Drug, Healthcare and Patient Safety 2016, 8:91-100
Published Date: 13 December 2016
Pattern of chemotherapy-related adverse effects among adult cancer patients treated at Gondar University Referral Hospital, Ethiopia: a cross-sectional study
Belachew SA, Erku DA, Mekuria AB, Gebresillassie BM
Drug, Healthcare and Patient Safety 2016, 8:83-90
Published Date: 8 December 2016
Positive clinical outcomes derived from using Streptococcus salivarius K12 to prevent streptococcal pharyngotonsillitis in children: a pilot investigation
Di Pierro F, Colombo M, Zanvit A, Rottoli AS
Drug, Healthcare and Patient Safety 2016, 8:77-81
Published Date: 21 November 2016
Point prevalence of hospital-acquired infections in two teaching hospitals of Amhara region in Ethiopia
Yallew WW, Kumie A, Yehuala FM
Drug, Healthcare and Patient Safety 2016, 8:71-76
Published Date: 23 August 2016
Extent of dispensing prescription-only medications without a prescription in community drug retail outlets in Addis Ababa, Ethiopia: a simulated-patient study
Erku DA, Mekuria AB, Surur AS, Gebresillassie BM
Drug, Healthcare and Patient Safety 2016, 8:65-70
Published Date: 14 July 2016
Topiramate-induced maculopathy in IgG4-related disease
DaCosta J, Younis S
Drug, Healthcare and Patient Safety 2016, 8:59-63
Published Date: 8 June 2016
The virgin land of quality management: a first measure of patient safety climate at the National Hospital of the Faroe Islands
Kristensen S, Túgvustein N, Zachariassen H, Sabroe S, Bartels P, Mainz J
Drug, Healthcare and Patient Safety 2016, 8:49-57
Published Date: 26 April 2016
Seasonality in acute liver injury? Findings in two health care claims databases
Weinstein RB, Schuemie MJ, Ryan PB, Stang PE
Drug, Healthcare and Patient Safety 2016, 8:39-48
Published Date: 31 March 2016
Safety of apixaban for venous thromboembolism prophylaxis: the evidence to date
Trkulja V
Drug, Healthcare and Patient Safety 2016, 8:25-38
Published Date: 18 February 2016
Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia
Bhusal S, Diomampo S, Magrey MN
Drug, Healthcare and Patient Safety 2016, 8:13-23
Published Date: 17 February 2016
A fatal adverse effect of cefazolin administration: severe brain edema in a patient with multiple meningiomas
Tribuddharat S, Sathitkarnmanee T, Kitkhuandee A, Theerapongpakdee S, Ngamsaengsirisup K, Chanthawong S
Drug, Healthcare and Patient Safety 2016, 8:9-12
Published Date: 9 February 2016
Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
Pugliese D, Felice C, Landi R, Papa A, Guidi L, Armuzzi A
Drug, Healthcare and Patient Safety 2016, 8:1-7
Published Date: 3 February 2016
Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertension
Dodgen AL, Hill KD
Drug, Healthcare and Patient Safety 2015, 7:175-183
Published Date: 15 December 2015
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States
Jara M, Aquilina T, Aupperle P, Rabinowicz AL
Drug, Healthcare and Patient Safety 2015, 7:169-174
Published Date: 15 December 2015
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis
Gajofatto A, Turatti M, Monaco S, Benedetti MD
Drug, Healthcare and Patient Safety 2015, 7:157-167
Published Date: 11 December 2015
Challenges facing effective implementation of co-trimoxazole prophylaxis in children born to HIV-infected mothers in the public health facilities
Kamuhabwa AAR, Manyanga V
Drug, Healthcare and Patient Safety 2015, 7:147-156
Published Date: 29 October 2015
The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram
Friesen KJ, Bugden SC
Drug, Healthcare and Patient Safety 2015, 7:139-145
Published Date: 19 August 2015
Cardiovascular effects of hormone therapy for prostate cancer
Lester JF, Mason MD
Drug, Healthcare and Patient Safety 2015, 7:129-138
Published Date: 23 July 2015
Drug utilization in selected health facilities of South West Shoa Zone, Oromia Region, Ethiopia
Kebede M, Kebebe Borga D, Mulisa Bobasa E
Drug, Healthcare and Patient Safety 2015, 7:121-127
Published Date: 23 July 2015
Cardiovascular effects of basal insulins
Mannucci E, Giannini S, Dicembrini I
Drug, Healthcare and Patient Safety 2015, 7:113-120
Published Date: 10 July 2015
Prevalence and predictors of antibiotic prescription errors in an emergency department, Central Saudi Arabia
Alanazi MQ, Al-Jeraisy MI, Salam M
Drug, Healthcare and Patient Safety 2015, 7:103-111
Published Date: 4 June 2015
Antifungal agent utilization evaluation in hospitalized neutropenic cancer patients at a large teaching hospital
Vazin A, Davarpanah MA, Ghalehsoltani S
Drug, Healthcare and Patient Safety 2015, 7:97-102
Published Date: 1 June 2015
Environmental and host-related determinants of tuberculosis in Metema district, north-west Ethiopia
Tesema C, Tadesse T, Gebrehiwot M, Tsegaw A, Weldegebreal F
Drug, Healthcare and Patient Safety 2015, 7:87-95
Published Date: 27 May 2015
Determinant factors of tobacco use among ever-married men in Bangladesh
Rahman MS, Mondal MNI, Islam MR, Rahman MM, Hoque MN, Alam MS
Drug, Healthcare and Patient Safety 2015, 7:77-85
Published Date: 13 May 2015
Individualized recombinant human follicle-stimulating hormone dosing using the CONSORT calculator in assisted reproductive technology: a large, multicenter, observational study of routine clinical practice
Naether OGJ, Tandler-Schneider A, Bilger W
Drug, Healthcare and Patient Safety 2015, 7:69-76
Published Date: 15 April 2015
Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction
Nawroth F, Tandler-Schneider A, Bilger W
Drug, Healthcare and Patient Safety 2015, 7:63-68
Published Date: 15 April 2015
Patient-reported outcomes after discontinuation of long-term topical corticosteroid treatment for atopic dermatitis: a targeted cross-sectional survey
Takahashi-Ando N, Jones MA, Fujisawa S, Hama R
Drug, Healthcare and Patient Safety 2015, 7:57-62
Published Date: 7 April 2015
Survey on appropriateness of use of nimesulide in nine European countries
Franchi S, Heiman F, Visentin E, Sacerdote P
Drug, Healthcare and Patient Safety 2015, 7:51-55
Published Date: 16 March 2015
Persistent nonmalignant pain management using nonsteroidal anti-inflammatory drugs in older patients and use of inappropriate adjuvant medications
Rianon N, Knell ME, Agbor-Bawa W, Thelen J, Burkhardt C, Rasu RS
Drug, Healthcare and Patient Safety 2015, 7:43-50
Published Date: 29 January 2015
Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies
Goldstein JL, Cryer B
Drug, Healthcare and Patient Safety 2015, 7:31-41
Published Date: 22 January 2015
Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges
Epstein RA, Moore K, Bobo WV
Drug, Healthcare and Patient Safety 2015, 7:7-29
Published Date: 24 December 2014
Ability of Saudi mothers to appropriately and accurately use dosing devices to administer oral liquid medications to their children
Almazrou S, Alsahli H, Alwattar H, Alturki L, Alamri M
Drug, Healthcare and Patient Safety 2015, 7:1-6
Published Date: 22 December 2014
Frequency of medication errors in an emergency department of a large teaching hospital in southern Iran
Vazin A, Zamani Z, Hatam N
Drug, Healthcare and Patient Safety 2014, 6:179-184
Published Date: 11 December 2014
Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
DaCosta J, Younis S
Drug, Healthcare and Patient Safety 2014, 6:175-178
Published Date: 25 November 2014
Observational study of upper gastrointestinal tract bleeding events in patients taking duloxetine and nonsteroidal anti-inflammatory drugs: a case-control analysis
Li H, Cheng Y, Ahl J, Skljarevski V
Drug, Healthcare and Patient Safety 2014, 6:167-174
Published Date: 29 October 2014
Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam
Kamuhabwa AR, Charles E
Drug, Healthcare and Patient Safety 2014, 6:155-165
Published Date: 24 October 2014
Patient perceptions on the subject of medical research
Ventolini G, Goodwin B, Woody C
Drug, Healthcare and Patient Safety 2014, 6:151-153
Published Date: 17 October 2014
Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study
Denholm JT, McBryde ES, Eisen DP, Penington JS, Chen C, Street AC
Drug, Healthcare and Patient Safety 2014, 6:145-149
Published Date: 21 October 2014
Evaluation of bactericidal activity of Hannon honey on slowly growing bacteria in the chemostat
Sufya N, Matar N, Kaddura R, Zorgani A
Drug, Healthcare and Patient Safety 2014, 6:139-144
Published Date: 15 October 2014
Topical steroid addiction in atopic dermatitis
Fukaya M, Sato K, Sato M, Kimata H, Fujisawa S, Dozono H, Yoshizawa J, Minaguchi S
Drug, Healthcare and Patient Safety 2014, 6:131-138
Published Date: 14 October 2014
Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges
Epstein RA, Moore KM, Bobo WV
Drug, Healthcare and Patient Safety 2014, 6:109-129
Published Date: 18 September 2014
Validating administrative data for the detection of adverse events in older hospitalized patients
Ackroyd-Stolarz S, Bowles SK, Giffin L
Drug, Healthcare and Patient Safety 2014, 6:101-108
Published Date: 13 August 2014
Management of L-dopa overdose in the competitive inhibition state
Hinz M, Stein A, Cole T
Drug, Healthcare and Patient Safety 2014, 6:93-99
Published Date: 22 July 2014
Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems
Schjøtt J, Bergman J
Drug, Healthcare and Patient Safety 2014, 6:89-92
Published Date: 1 July 2014
New developments in the treatment of metastatic melanoma – role of dabrafenib–trametinib combination therapy
Luke JJ, Ott PA
Drug, Healthcare and Patient Safety 2014, 6:77-88
Published Date: 24 June 2014
Clinical potential, safety, and tolerability of arbaclofen in the treatment of autism spectrum disorder
Frye RE
Drug, Healthcare and Patient Safety 2014, 6:69-76
Published Date: 10 May 2014
Patient safety and minimizing risk with insulin administration – role of insulin degludec
Aye MM, Atkin SL
Drug, Healthcare and Patient Safety 2014, 6:55-67
Published Date: 30 April 2014
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
Urbanek I, Kaczmarek K, Cygankiewicz I, Ptaszynski P
Drug, Healthcare and Patient Safety 2014, 6:47-54
Published Date: 28 April 2014
Benefit–risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir
Gaetano JN
Drug, Healthcare and Patient Safety 2014, 6:37-45
Published Date: 31 March 2014
Efficacy, safety, and applicability of outpatient treatment for diverticulitis
Tursi A
Drug, Healthcare and Patient Safety 2014, 6:29-36
Published Date: 31 March 2014
Temporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper
de Araújo AN, do Nascimento MA, de Sena EP, Baptista AF
Drug, Healthcare and Patient Safety 2014, 6:21-27
Published Date: 10 March 2014
Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children
Di Pierro F, Colombo M, Zanvit A, Risso P, Rottoli AS
Drug, Healthcare and Patient Safety 2014, 6:15-20
Published Date: 13 February 2014
Pharmacists’ knowledge and attitudes about natural health products: a mixed-methods study
Kheir N, Gad HY, Abu-Yousef SE
Drug, Healthcare and Patient Safety 2014, 6:7-14
Published Date: 30 January 2014
Improving medication management after a hospitalization with pharmacist home visits and electronic personal health records: an observational study
Kogut SJ, Goldstein E, Charbonneau C, Jackson A, Patry G
Drug, Healthcare and Patient Safety 2014, 6:1-6
Published Date: 17 January 2014
The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports
Perahia DG, Bangs ME, Zhang Q, Cheng Y, Ahl J, Frakes EP, Adams MJ, Martinez JM
Drug, Healthcare and Patient Safety 2013, 5:211-219
Published Date: 25 November 2013
Woman presenting with chronic iron deficiency anemia associated with hereditary hemorrhagic telangiectasia: a case report
Stross P
Drug, Healthcare and Patient Safety 2013, 5:203-210
Published Date: 18 November 2013
Oral available agents in the treatment of RRMS
Aupérin T
Drug, Healthcare and Patient Safety 2013, 5:199-201
Published Date: 29 October 2013
Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature
Nasser M, Larsen TR, Waanbah B, Sidiqi I, McCullough PA
Drug, Healthcare and Patient Safety 2013, 5:191-198
Published Date: 26 September 2013
Knowledge among drug dispensers and antimalarial drug prescribing practices in public health facilities in Dar es Salaam
Kamuhabwa AA, Silumbe R
Drug, Healthcare and Patient Safety 2013, 5:181-189
Published Date: 2 September 2013
Attrition of Canadian Internet pharmacy websites: what are the implications?
Veronin MA, Clancy KM
Drug, Healthcare and Patient Safety 2013, 5:171-179
Published Date: 15 August 2013
A proposal for a drug information database and text templates for generating package inserts
Okuya R, Kimura M, Ohkura M, Tsuchiya F
Drug, Healthcare and Patient Safety 2013, 5:161-169
Published Date: 29 July 2013
Patient considerations in the use of tapentadol for moderate to severe pain
Vadivelu N, Huang Y, Mirante B, Jacoby M, Braveman FR, Hines RL, Sinatra R
Drug, Healthcare and Patient Safety 2013, 5:151-159
Published Date: 3 July 2013
Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study
Sato I, Akazawa M
Drug, Healthcare and Patient Safety 2013, 5:143-150
Published Date: 24 June 2013
Update on the safety and bioequivalence of biosimilars – focus on enoxaparin
Jeske W, Walenga JM, Hoppensteadt D, Fareed J
Drug, Healthcare and Patient Safety 2013, 5:133-141
Published Date: 10 June 2013
Risky substance exposure during pregnancy: a pilot study from Lebanese mothers
Rachidi S, Awada S, Al-Hajje A, Bawab W, Zein S, Saleh N, Salameh P
Drug, Healthcare and Patient Safety 2013, 5:123-131
Published Date: 15 May 2013
Non-small cell lung cancer therapy: safety and efficacy in the elderly
Glotzer OS, Fabian T, Chandra A, Bakhos CT
Drug, Healthcare and Patient Safety 2013, 5:113-121
Published Date: 22 April 2013
Pharmacovigilance as a tool for safety and monitoring: a review of general issues and the specific challenges with end-stage renal failure patients
Jacob D, Marron B, Ehrlich J, Rutherford PA
Drug, Healthcare and Patient Safety 2013, 5:105-112
Published Date: 15 April 2013
Diagnostic sensitivity for invasive cervical carcinoma of high risk HPV tests performed on SurePath™ liquid-based pap specimens
Nance KV
Drug, Healthcare and Patient Safety 2013, 5:101-104
Published Date: 31 March 2013
Clinical use of anti-TNF therapy and increased risk of infections
Ali T, Kaitha S, Mahmood S, Ftesi A, Stone J, Bronze MS
Drug, Healthcare and Patient Safety 2013, 5:79-99
Published Date: 28 March 2013
Clinical utility and tolerability of linagliptin in diabetic patients
Maxwell LG, McFarland MS
Drug, Healthcare and Patient Safety 2013, 5:67-78
Published Date: 22 March 2013
Patient safety in orthopedic surgery: prioritizing key areas of iatrogenic harm through an analysis of 48,095 incidents reported to a national database of errors
Panesar SS, Carson-Stevens A, Salvilla SA, Patel B, Mirza SB, Mann B
Drug, Healthcare and Patient Safety 2013, 5:57-65
Published Date: 24 March 2013
Safety and tolerability of inhalational anticholinergics in COPD
Sharafkhaneh A, Majid H, Gross NJ
Drug, Healthcare and Patient Safety 2013, 5:49-55
Published Date: 8 March 2013
Oral available agents in the treatment of relapsing remitting multiple sclerosis an overview of merits and culprits
Thöne J, Ellrichmann G
Drug, Healthcare and Patient Safety 2013, 5:37-47
Published Date: 26 February 2013
Prescription painkillers and controlled substances: an appraisal of drug information provided by six US pharmacies
Gill PS
Drug, Healthcare and Patient Safety 2013, 5:29-36
Published Date: 25 February 2013
Alcohol and prescription drug safety in older adults
Zanjani F, Hoogland AI, Downer BG
Drug, Healthcare and Patient Safety 2013, 5:13-27
Published Date: 25 February 2013
Application of basic pharmacology and dispensing practice of antibiotics in accredited drug-dispensing outlets in Tanzania
Minzi OM, Manyilizu VS
Drug, Healthcare and Patient Safety 2013, 5:5-11
Published Date: 30 January 2013
Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening
Nance KV
Drug, Healthcare and Patient Safety 2013, 5:1-3
Published Date: 21 January 2013
Antipsychotic agents: efficacy and safety in schizophrenia
de Araújo AN, de Sena EP, de Oliveira IR, Juruena MF
Drug, Healthcare and Patient Safety 2012, 4:173-180
Published Date: 29 November 2012
Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening
Naryshkin S, Austin RM
Drug, Healthcare and Patient Safety 2012, 4:167-172
Published Date: 2 November 2012
The economic burden of patient safety targets in acute care: a systematic review
Mittmann N, Koo M, Daneman N, McDonald A, Baker M, Matlow A, Krahn M, Shojanai KG, Etchells E
Drug, Healthcare and Patient Safety 2012, 4:141-165
Published Date: 5 October 2012
A review and additional post-hoc analyses of the incidence and impact of constipation observed in darifenacin clinical trials
Tack J, Wyndaele JJ, Ligozio G, Egermark M
Drug, Healthcare and Patient Safety 2012, 4:127-139
Published Date: 27 September 2012
Analysis of indoor air pollutants checklist using environmetric technique for health risk assessment of sick building complaint in nonindustrial workplace
Syazwan AI, Mohd Rafee B, Juahir H, Azman AZ, Nizar AM, Izwyn Z, Syahidatussyakirah K, Muhaimin AA, Syafiq Yunos MA, Anita AR, Muhamad Hanafiah J, Shaharuddin MS, Mohd Ibthisham A, Mohd Hasmadi I, Mohamad Azhar MN, Azizan HS, Zulfadhli I, Othman J, Rozalini M, Kamarul FT
Drug, Healthcare and Patient Safety 2012, 4:107-126
Published Date: 21 September 2012
Developing a tool to preserve eye contact with patients undergoing colonoscopy for pain monitoring
Niv Y, Tal Y
Drug, Healthcare and Patient Safety 2012, 4:103-105
Published Date: 24 August 2012
Clinical use of antidepressant therapy and associated cardiovascular risk
Waring WS
Drug, Healthcare and Patient Safety 2012, 4:93-101
Published Date: 17 August 2012
Signal detection to identify serious adverse events (neuropsychiatric events) in travelers taking mefloquine for chemoprophylaxis of malaria
Naing C, Aung K, Ahmed SI, Mak JW
Drug, Healthcare and Patient Safety 2012, 4:87-92
Published Date: 3 August 2012
Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy
Ciliberto MA, Weisenberg JL, Wong M
Drug, Healthcare and Patient Safety 2012, 4:81-86
Published Date: 26 July 2012
Adverse drug reactions in older patients: an Italian observational prospective hospital study
Conforti A, Costantini D, Zanetti F, Moretti U, Grezzana M, Leone R
Drug, Healthcare and Patient Safety 2012, 4:75-80
Published Date: 17 July 2012
Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap
Page RL 2nd, Ghushchyan V, Allen RR, Roper L, Beck D, Johnathan BH, Frech-Tamas F, Chan W, McQueen RB, Nair KV
Drug, Healthcare and Patient Safety 2012, 4:67-74
Published Date: 10 July 2012
Awareness among nurses about reporting of adverse drug reactions in Sweden
Ekman E, Petersson G, Tågerud S, Bäckström M
Drug, Healthcare and Patient Safety 2012, 4:61-66
Published Date: 28 June 2012
Knowledge of drug prescription in dentistry students
Guzmán-Álvarez R, Medeiros M, Reyes-Lagunes LI, Campos-Sepúlveda AE
Drug, Healthcare and Patient Safety 2012, 4:55-59
Published Date: 19 June 2012
Specific safety and tolerability considerations in the use of anticonvulsant medications in children
Crepeau A, Moseley BD, Wirrell EC
Drug, Healthcare and Patient Safety 2012, 4:39-54
Published Date: 6 June 2012
Evaluation of medication package inserts in Saudi Arabia
Al-aqeel SA
Drug, Healthcare and Patient Safety 2012, 4:33-38
Published Date: 26 March 2012
Self-initiation of antiretroviral therapy in the developing world: the involvement of private pharmacies in an HIV program
Minzi OM, Buma D, Kagashe GA
Drug, Healthcare and Patient Safety 2012, 4:27-31
Published Date: 29 March 2012
Analysis on descriptions of precautionary statements in package inserts of medicines
Nabeta K, Kimura M, Ohkura M, Tsuchiya F
Drug, Healthcare and Patient Safety 2012, 4:19-25
Published Date: 24 February 2012
Feasibility of home management using ACT for childhood malaria episodes in an urban setting
Nsagha DS, Elat JBN, Ndong PAB, Tata PN, Tayong MN, Pokem F, Wankah CC
Drug, Healthcare and Patient Safety 2012, 4:1-18
Published Date: 29 December 2011
Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer
Choi S, Lee AK
Drug, Healthcare and Patient Safety 2011, 3:107-119
Published Date: 22 December 2011
An exploratory study on medications in Qatar homes
Kheir N, El Hajj MS, Wilbur K, Kaissi RML, Yousif A
Drug, Healthcare and Patient Safety 2011, 3:99-106
Published Date: 20 December 2011
Is advertising ethical for dentists? An insight into the Indian scenario
Dable RA, Prasanth MA, Singh SB, Nazirkar GS
Drug, Healthcare and Patient Safety 2011, 3:93-98
Published Date: 16 December 2011
Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis
Lewiecki EM
Drug, Healthcare and Patient Safety 2011, 3:79-91
Published Date: 1 December 2011
Monoamine depletion by reuptake inhibitors
Hinz M, Stein A, Uncini T
Drug, Healthcare and Patient Safety 2011, 3:69-77
Published Date: 20 October 2011
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Noreddin AM, Elkhatib WF, Cunnion KM, Zhanel GG
Drug, Healthcare and Patient Safety 2011, 3:59-68
Published Date: 7 October 2011
Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study
Hafermann MJ, Namdar R, Seibold GE, Page RL 2nd
Drug, Healthcare and Patient Safety 2011, 3:53-58
Published Date: 3 October 2011
Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the US
Schumock GT, Gibbons RD, Lee TA, Joo MJ, Valuck RJ, Stayner LT
Drug, Healthcare and Patient Safety 2011, 3:47-52
Published Date: 8 September 2011
Trigeminal neuralgia: successful antiepileptic drug combination therapy in three refractory cases
Prisco L, Ganau M, Bigotto F, Zornada F
Drug, Healthcare and Patient Safety 2011, 3:43-45
Published Date: 10 August 2011
Should benefit–risk assessment have its own drug “label”?
Braithwaite RS
Drug, Healthcare and Patient Safety 2011, 3:37-41
Published Date: 3 August 2011
Prevalence and factors associated with off-label antidepressant prescriptions for insomnia
Lai L, Tan MH, Lai YC
Drug, Healthcare and Patient Safety 2011, 3:27-36
Published Date: 8 July 2011
Complications in endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS): analysis of 7-year physician-reported adverse events
Niv Y, Gershtansky Y, Kenett RS, Tal Y, Birkenfeld S
Drug, Healthcare and Patient Safety 2011, 3:21-25
Published Date: 21 June 2011
Suicidal behavior and antiepileptic drugs in epilepsy: analysis of the emerging evidence
Mula M, Hesdorffer DC
Drug, Healthcare and Patient Safety 2011, 3:15-20
Published Date: 16 June 2011
Twelve cases of drug-induced blepharospasm improved within 2 months of psychotropic cessation
Emoto Y, Emoto H, Oishi E, Hikita S, Wakakura M
Drug, Healthcare and Patient Safety 2011, 3:9-14
Published Date: 3 June 2011
Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease
David N Roberts, Philip B Miner
Drug, Healthcare and Patient Safety 2011, 3:1-8
Published Date: 3 March 2011
TNF-α inhibitors: are they carcinogenic?
αGirindra Raval, Paulette Mehta
Drug, Healthcare and Patient Safety 2010, 2:241-247
Published Date: 6 December 2010
Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases
Paul A Gurbel, Udaya S Tantry, Dean J Kereiakes
Drug, Healthcare and Patient Safety 2010, 2:233-240
Published Date: 15 November 2010
Insomnia medication use and the probability of an accidental event in an older adult population
Alon Y Avidan, Liisa A Palmer, Justin F Doan, et al
Drug, Healthcare and Patient Safety 2010, 2:225-232
Published Date: 12 November 2010
Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs
Kitty Poon, Allen B King
Drug, Healthcare and Patient Safety 2010, 2:213-223
Published Date: 28 October 2010
Safety and tolerability of antipsychotics: focus on amisulpride
Mario F Juruena, Eduardo Pondé de Sena, Irismar Reis de Oliveira
Drug, Healthcare and Patient Safety 2010, 2:205-211
Published Date: 1 October 2010
Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin
Harald Vonkeman, Inger Meek, Mart van de Laar
Drug, Healthcare and Patient Safety 2010, 2:191-204
Published Date: 6 October 2010
Antiepileptic drugs and suicidality
Jeffery W Britton, Jerry J Shih
Drug, Healthcare and Patient Safety 2010, 2:181-189
Published Date: 28 September 2010
Safety and clinical efficacy of golimumab in the treatment of arthritides
Ismail Simsek, Yusuf Yazici
Drug, Healthcare and Patient Safety 2010, 2:169-180
Published Date: 28 September 2010
Profound thrombocytopenia after primary exposure to eptifibatide
Nicholas B Norgard, Brian T Badgley
Drug, Healthcare and Patient Safety 2010, 2:163-167
Published Date: 21 September 2010
Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: Safety, tolerability, and efficacy
Mitchell S Buckley, Robin L Staib, Laura M Wicks, et al
Drug, Healthcare and Patient Safety 2010, 2:151-161
Published Date: 20 September 2010
Antidepressant-associated sexual dysfunction: impact, effects, and treatment
Agnes Higgins, Michael Nash, Aileen M Lynch
Drug, Healthcare and Patient Safety 2010, 2:141-150
Published Date: 9 September 2010
A danger of induction of Brugada syndrome during pill-in-the-pocket therapy for paroxysmal atrial fibrillation
Yoshiyasu Aizawa, Tomohiro Matsuhashi, Toshiaki Sato, et al
Drug, Healthcare and Patient Safety 2010, 2:139-140
Published Date: 25 August 2010
Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
Luca Dalle Carbonare, Mirko Zanatta, Adriano Gasparetto, et al
Drug, Healthcare and Patient Safety 2010, 2:121-137
Published Date: 19 August 2010
Efficacy, tolerability and safety of biologic therapy in rheumatoid disease: patient considerations
Sarah Horton, Maya H Buch, Paul Emery
Drug, Healthcare and Patient Safety 2010, 2:101-119
Published Date: 17 August 2010
Development of indicators for identifying adverse drug events in an Indian tertiary care teaching hospital
Rajakannan Thiyagu, Surulivel R Mallayasamy, Valakkathala Rajesh, et al
Drug, Healthcare and Patient Safety 2010, 2:95-100
Published Date: 30 June 2010
Incorrect description of mode of excretion of linagliptin
Hans-Juergen Woerle, Sanjay Patel
Drug, Healthcare and Patient Safety 2010, 2:93-94
Published Date: 2 June 2010
Safety and clinical efficacy of everolimus in the treatment of advanced renal cell carcinoma (RCC)
Rohan Shahani, Kevin G Kwan, Anil Kapoor
Drug, Healthcare and Patient Safety 2010, 2:85-91
Published Date: 28 June 2010
Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension
Parul Ichhpujani, L Jay Katz
Drug, Healthcare and Patient Safety 2010, 2:73-83
Published Date: 24 May 2010
Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia
Adie Viljoen, Anthony S Wierzbicki
Drug, Healthcare and Patient Safety 2010, 2:61-71
Published Date: 24 May 2010
Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options
Juraj Payer, Kristina Brazdilova, Peter Jackuliak
Drug, Healthcare and Patient Safety 2010, 2:49-59
Published Date: 20 May 2010
Preclinical pharmacology, efficacy, and safety of varenicline in smoking cessation and clinical utility in high risk patients
Zheng-Xiong Xi
Drug, Healthcare and Patient Safety 2010, 2:39-48
Published Date: 14 April 2010
Clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections
Dionissios Neofytos, Edina Avdic, Anna-Pelagia Magiorakos
Drug, Healthcare and Patient Safety 2010, 2:27-38
Published Date: 20 April 2010
Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers
Elisabet Ekman, Staffan Hägg, Anders Sundström, et al
Drug, Healthcare and Patient Safety 2010, 2:21-25
Published Date: 29 March 2010
Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy
Mary Elizabeth Cox, Jennifer Rowell, Leonor Corsino, et al
Drug, Healthcare and Patient Safety 2010, 2:7-19
Published Date: 28 January 2010
Beyond the black box: drug- and device-associated hypersensitivity events
Charles L Bennett, Olatokunbo S Adegboro, Elizabeth A Calhoun, Dennis Raisch
Drug, Healthcare and Patient Safety 2010, 2:1-5
Published Date: 16 February 2010
29 gauge needles improve patient satisfaction over 27 gauge needles for daily glatiramer acetate injections
Stephen Glenski, Jill Conner
Drug, Healthcare and Patient Safety 2009, 1:81-86
Published Date: 9 December 2009
Pharmacist-documented interventions during the dispensing process in a primary health care facility in Qatar
Richard Hooper, Abdullah Adam, Nadir Kheir
Drug, Healthcare and Patient Safety 2009, 1:73-80
Published Date: 30 November 2009
Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
Alaa Rostom, Katherine Muir, Catherine Dube, et al
Drug, Healthcare and Patient Safety 2009, 1:47-71
Published Date: 28 October 2009
Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
Zhengwu Lu
Drug, Healthcare and Patient Safety 2009, 1:35-45
Published Date: 15 October 2009
Long-term use of rosuvastatin: a critical risk benefit appraisal and comparison with other antihyperlipidemics
Leonardo Calza
Drug, Healthcare and Patient Safety 2009, 1:25-33
Published Date: 28 August 2009
Use of X-ray fluoroscopy in orthopedic operations: The patient’s perspective
Zain Ul-Abadin, Faisal rauf Khan, Shams Rauf, Nadia Rauf
Drug, Healthcare and Patient Safety 2009, 1:21-24
Published Date: 18 June 2009
Severe hepatotoxic adverse reaction in a healthy schoolgirl after treatment with flucloxacillin
C-J Törnhage, G Brunlöf, S M Wallerstedt
Drug, Healthcare and Patient Safety 2009, 1:17-19
Published Date: 31 March 2009
Polycystic ovary syndrome and its impact on women’s quality of life: More than just an endocrine disorder
Christine Brady, Shaymaa S Mousa, Shaker A Mousa
Drug, Healthcare and Patient Safety 2009, 1:9-15
Published Date: 3 February 2009
Anti-metallothionein IgG and levels of metallothionein in autistic children with GI disease
A J Russo
Drug, Healthcare and Patient Safety 2009, 1:1-8
Published Date: 8 January 2009